ATLAS VENTURE PARALLEL FUND V-B C V's Net Worth

$356 Million

Estimate Recalculated Jul 12, 2024 07:04PM EST

Who is ATLAS VENTURE PARALLEL FUND V-B C V?

ATLAS VENTURE PARALLEL FUND V-B C V has an estimated net worth of $356 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., Phase Forward Inc, and MOMENTA PHARMACEUTICALS INC.

SEC CIK

ATLAS VENTURE PARALLEL FUND V-B C V's CIK is 0001133790

Past Insider Trading and Trends

2004 was ATLAS VENTURE PARALLEL FUND V-B C V's most active year for acquiring shares with 45 total transactions. ATLAS VENTURE PARALLEL FUND V-B C V's most active month to acquire stocks was the month of May. 2005 was ATLAS VENTURE PARALLEL FUND V-B C V's most active year for disposing of shares, totalling 39 transactions. ATLAS VENTURE PARALLEL FUND V-B C V's most active month to dispose stocks was the month of May. 2004 saw ATLAS VENTURE PARALLEL FUND V-B C V paying a total of $6,926,000.00 for 12,062,158 shares, this is the most they've acquired in one year. In 2005 ATLAS VENTURE PARALLEL FUND V-B C V cashed out on 6,463,650 shares for a total of $8,966,824.76, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $169.07

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-33.33%
-1.34M
—
—
2.67M
Sep 29
Form 4
+801.66%
3.57M
—
—
4.01M
Jun 3
Form 4/A
∞
445K
$6.00
$2,670,000.00
445K
May 27
Form 4
∞
445K
$6.00
$2,670,000.00
445K
May 27 - Jun 1
Form 3
—
0
—
—
0
No matching records found

Phase Forward Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-36.45%
-1.25M
—
—
2.18M
Oct 10
Form 4
-5.25%
-190.00K
$8.97
-$1,704,300.00
3.43M
Sep 14
Form 4
-1.87%
-138.29K
$8.46
-$1,169,767.24
7.24M
Sep 9 - Sep 12
Form 4
-1.46%
-111.71K
$8.27
-$924,300.52
7.52M
Sep 7 - Sep 8
Form 4
-1.15%
-45.00K
$7.61
-$342,450.00
3.87M
Jun 14
Form 4
-1.26%
-50.00K
$6.93
-$346,500.00
3.91M
Jun 9
Form 4
-1.28%
-154.62K
$6.82
-$1,054,507.00
11.89M
Jun 6 - Jun 8
Form 4
-10.82%
-500.00K
$6.85
-$3,425,000.00
4.12M
Mar 14
Form 3
—
0
—
—
0
No matching records found

MOMENTA PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-19.16%
-1.17M
—
—
4.92M
Aug 3
Form 4
-20.00%
-1.52M
—
—
6.08M
Jul 5
Form 4
+3,016.71%
7.36M
—
—
7.6M
Jun 25
Form 4
∞
244K
$6.50
$1,586,000.00
244K
Jun 21
Form 3
—
0
—
—
0
No matching records found